Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels

Campos-Melo, Danae; Droppelmann, Cristian A.; Zhongping He; Volkening, Kathryn; Strong, Michael J.
June 2013
Molecular Brain;2013, Vol. 6 Issue 1, p1
Academic Journal
Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive, adult onset, fatal neurodegenerative disease of motor neurons. There is emerging evidence that alterations in RNA metabolism may be critical in the pathogenesis of ALS. MicroRNAs (miRNAs) are small non-coding RNAs that are key determinants of mRNA stability. Considering that miRNAs are increasingly being recognized as having a role in a variety of neurodegenerative diseases, we decided to characterize the miRNA expression profile in spinal cord (SC) tissue in sporadic ALS (sALS) and controls. Furthermore, we performed functional analysis to identify a group of dysregulated miRNAs that could be responsible for the selective suppression of low molecular weight neurofilament (NFL) mRNA observed in ALS. Results: Using TaqMan arrays we analyzed 664 miRNAs and found that a large number of miRNAs are differentially expressed in ventral lumbar SC in sALS compared to controls. We observed that the majority of dysregulated miRNAs are down-regulated in sALS SC tissues. Ingenuity Pathway Analysis (IPA) showed that dysregulated miRNAs are linked with nervous system function and cell death. We used two prediction algorithms to develop a panel of miRNAs that have recognition elements within the human NFL mRNA 3'UTR, and then we performed functional analysis for these miRNAs. Our results demonstrate that three miRNAs that are dysregulated in sALS (miR-146a*, miR-524-5p and miR-582-3p) are capable of interacting with NFL mRNA 3′UTR in a manner that is consistent with the suppressed steady state mRNA levels observed in spinal motor neurons in ALS. Conclusions: The miRNA expression profile is broadly altered in the SC in sALS. Amongst these is a group of dysregulated miRNAs directly regulate the NFL mRNA 3'UTR, suggesting a role in the selective suppression of NFL mRNA in the ALS spinal motor neuron neurofilamentous aggregate formation.


Related Articles

  • Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis. Ishtiaq, Muhammad; Campos-Melo, Danae; Volkening, Kathryn; Strong, Michael J. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive motor neuron degeneration and neurofilament aggregate formation. Spinal motor neurons in ALS also show a selective suppression in the levels of low molecular weight neurofilament (NEFL) mRNA. We have been...

  • Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS. Wuolikainen, Anna; Moritz, Thomas; Marklund, Stefan L.; Antti, Henrik; Andersen, Peter Munch // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background/Aim: The changes in the cerebrospinal fluid (CSF) metabolome associated with the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) are poorly understood and earlier smaller studies have shown conflicting results. The metabolomic methodology is suitable for screening...

  • Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. Igaz, Lionel M.; Kwong, Linda K.; Lee, Edward B.; Chen-Plotkin, Alice; Swanson, Eric; Unger, Travis; Malunda, Joe; Yan Xu; Winton, Matthew J.; Trojanowski, John Q.; Lee, Virginia M.-Y. // Journal of Clinical Investigation;Feb2011, Vol. 121 Issue 2, p726 

    Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by cytoplasmic protein aggregates in the brain and spinal cord that include TAR-DNA binding protein 43 (TDP-43). TDP-43 is normally localized in the nucleus with roles in the regulation of gene...

  • Motor-neuron disease: Rogue gene in the family. Sleegers, Kristel; Van Broeckhoven, Christine // Nature;3/26/2009, Vol. 458 Issue 7237, p415 

    This article discusses research conducted on the potential that heritable forms of the motor-neuron disease amyotrophic lateral sclerosis (ALS) are caused by mutations in the FUS gene. ALS is an incurable, disabling disease that degenerates neurons, causing progressive atrophy and spasticity....

  • Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Ikuko Takahashi; Yuka Hama; Masaaki Matsushima; Makoto Hirotani; Takahiro Kano; Hideki Hohzen; Ichiro Yabe; Jun Utsumi; Hidenao Sasaki // Molecular Brain;10/24/2015, Vol. 8, p1 

    Background: Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, which leads to the loss of upper and lower motor neurons, with a currently unknown etiology. Specific biomarkers could help in early detection and diagnosis, and could also act as indicators of disease...

  • A Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis. Brown, Robert H. // New England Journal of Medicine;10/20/94, Vol. 331 Issue 16, p1091 

    Comments on a report by Gurney, et al which favors the gain-of-function hypothesis in familial amyotrophic lateral sclerosis (ALS). Development, by Gurney and his colleagues of a strain of mice possessing the two normal mouse SOD1 genes and extra copies of the human gene for SOD1.

  • Bent out of shape.  // Newsweek;8/30/1993, Vol. 122 Issue 9, p61 

    Reports that scientists at Northwestern University and the Scripps Research Institute have discovered how the defective gene which causes Lou Gehrig's disease kills. Why this finding raises hope that the fatal disease can be treated; Additional information.

  • Fatal flaw. Cohen, Philip // New Scientist;04/04/98, Vol. 158 Issue 2128, p21 

    Focuses on genetic malfunction which attribute to amyotrophic lateral sclerosis (ALS) and other unexplained illnesses. Indication that healthy genes produce toxic proteins; Comments from Jeffrey Rothstein of John Hopkins University in Maryland; Findings of ALS studies conducted by Rothstein and...

  • ALS awareness. Common Cause?  // PN;Nov2011, Vol. 65 Issue 11, p21 

    The article offers information on the new gene change in the amyotrophic lateral sclerosis (ALS) identified by the investigators from the Northwestern University Feinberg School of Medicine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics